Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NVCN

Neovasc (NVCN) Stock Price, News & Analysis

Neovasc logo

About Neovasc Stock (NASDAQ:NVCN)

Advanced Chart

Key Stats

Today's Range
$30.03
$30.03
50-Day Range
$29.03
$30.03
52-Week Range
$4.59
$30.07
Volume
1 shs
Average Volume
56,993 shs
Market Capitalization
$82.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

NVCN Stock News Headlines

Closing Bell: Neovasc Inc down on Tuesday (NVCN)
Closing Bell: Neovasc Inc up on Monday (NVCN)
Biotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B market
A small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of the market’s most overlooked opportunities today. NanoViricides, Inc. (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral now in human trials, with activity against COVID-19, RSV, influenza, measles, and most recently Mpox. With Phase II trials approved in Africa for the deadliest Mpox strain, the timing couldn’t be more critical.
Neovasc Announces German Reimbursement Renewal
See More Headlines

NVCN Stock Analysis - Frequently Asked Questions

Neovasc Inc. (NASDAQ:NVCN) posted its earnings results on Tuesday, November, 9th. The medical equipment provider reported ($2.75) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.25) by $0.50. The medical equipment provider earned $0.70 million during the quarter, compared to analysts' expectations of $1.20 million. Neovasc had a negative net margin of 1,082.92% and a negative trailing twelve-month return on equity of 127.25%.

Shares of Neovasc reverse split on the morning of Friday, April 29th 2022.The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Micron Technology (MU) and Canopy Growth (CGC).

Company Calendar

Last Earnings
11/09/2021
Today
8/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NVCN
CIK
1399708
Employees
49
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($15.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$41.20 million
Net Margins
-1,082.92%
Pretax Margin
-1,082.26%
Return on Equity
-127.25%
Return on Assets
-80.31%

Debt

Debt-to-Equity Ratio
0.80
Current Ratio
2.96
Quick Ratio
2.85

Sales & Book Value

Annual Sales
$3.81 million
Price / Sales
21.60
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.77 per share
Price / Book
5.20

Miscellaneous

Outstanding Shares
2,740,000
Free Float
N/A
Market Cap
$82.28 million
Optionable
Not Optionable
Beta
1.70

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:NVCN) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners